Drug Therapy in Brugada Syndrome

E-ISSN： 1875-5895|5|5|409-417

ISSN： 1568-0061

Source： Current Drug Targets - Cardiovascular & Hematological Disorders, Vol.5, Iss.5, 2005-01, pp. : 409-417

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of tyrosine kinase inhibitors in a patient with Brugada syndrome and chronic myeloid leukemia

By Sgherza Nicola Russo Rossi Antonella Colonna Paolo Carluccio Paola Delia Mario Specchia Giorgina

International Journal of Hematology, Vol. 98, Iss. 4, 2013-10 ,pp. : 483-486

Springer Publishing Company

Access to resources Recommend Favorite

Novel mutations in domain I of SCN5A cause Brugada syndrome

By Vatta M. Dumaine R. Antzelevitch C. Brugada R. Li H. Bowles N.E. Nademanee K. Brugada J. Brugada P. Towbin J.A.

Molecular Genetics and Metabolism, Vol. 75, Iss. 4, 2002-04 ,pp. : 317-324

Academic Press

Access to resources Recommend Favorite

Drug therapy in Behçet's disease

By Okada Annabelle A.

Ocular Immunology and Inflammation, Vol. 8, Iss. 2, 2000-06 ,pp. : 85-91

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics of Obesity Drug Therapy

Current Molecular Medicine, Vol. 14, Iss. 7, 2014-08 ,pp. : 891-908

Bentham Science Publishers

Access to resources Recommend Favorite

Conventional Therapy of Sjogren’s Syndrome

Clinical Reviews in Allergy and Immunology, Vol. 32, Iss. 3, 2007-06 ,pp. : 284-291

Humana Press, Inc

Access to resources Recommend Favorite